Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Eur Rev Med Pharmacol Sci ; 19(16): 2964-72, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26367714

RESUMO

OBJECTIVE: We sought to investigate the intervention effect of nicotine on ß-amyloid (Aß)25-35 protein cytotoxicity in the rat basal forebrain neurons primary cultures. MATERIALS AND METHODS: For this purpose, freshly isolated rat basal forebrain neurons were cultured for 7 days and then exposed to either Aß(25-35) or the combination of Aß(25-35) and nicotine for 48 hours. The effects of Aß(25-35) and nicotine on neurons morphology, growth status and TrkA expression were evaluated through microscopy, MTT assay, RT-PCR and immunocytochemistry. RESULTS: We found that the exposure of cultured neurons to Aß(25-35) resulted in remarkable morphological changes. The average process number and length as well as the maximum process length of neurons were significantly decreased as compared with those of control. MTT assay showed that Aß(25-35) impaired the growth of neurons. Aß(25-35) also inhibited the expression of TrkA at both mRNA and protein levels. However, the addition of nicotine significantly attenuated these changes, indicating that nicotine could protect the neurons from the cytotoxicity of Aß(25-35). CONCLUSIONS: Nicotine could be useful for the treatment of Alzheimer's disease through its ability to rescue the neurons from Aß(25-35) cytotoxicity and the protective effect involved upregulated expression of TrkA receptors.


Assuntos
Doença de Alzheimer/tratamento farmacológico , Peptídeos beta-Amiloides/metabolismo , Prosencéfalo Basal/patologia , Neurônios/efeitos dos fármacos , Nicotina/uso terapêutico , Fragmentos de Peptídeos/farmacologia , Animais , Nicotina/farmacologia , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA